Pharmaniaga Of Malaysia Sees Sales Surge From Generics Demand
This article was originally published in PharmAsia News
Malaysia's generics makers expect to reap benefits from the global financial crisis as an increasing number of patients in developing countries turn to cheaper drugs. Pharmaniaga's managing director, Mohamad Abdullah, said his company alone hopes to increase its international sales by 5 percent next year and keep growing until it becomes a billion-dollar company by 2013. He said increased sales in Fiji, Myanmar and Vietnam have led strong sales this year. Pharmaniaga plans to launch 14 new products a year, some from branded firms in Europe and in Egypt and Indonesia. (Click here for more
You may also be interested in...
A new report focused on the European market says that winning trust is the key to taking AI adoption to the next stage. That approach was praised by MedTech Europe CEO Serge Bernasconi.
As the transition period following the UK’s withdrawal from the European Union draws to a close, cosmetics industry stakeholders are following final trade negotiations while readying themselves for new regulatory complexities.
Purdue’s opioid settlement is making headlines for the size of the financial penalty. But the plan to re-imagine Purdue as a ‘public benefit company’ could have far-reaching significance for the industry – if it ever gets off the ground.